Development of a tau-V337M mouse model using CRISPR/Cas9 system and enhanced ssODN-mediated recombination.
- Author:
Lijiao CHEN
1
;
Li DENG
1
;
Wenjie SUN
1
;
Jie LIU
1
;
Ting ZHANG
1
;
Shangang LI
1
Author Information
- Publication Type:Journal Article
- Keywords: Alzheimer's disease; Cas9; DNA recombination; Rad51; tau-V337M; unilateral oviduct transplantation
- MeSH: Animals; Male; Female; Mice; Humans; CRISPR-Cas Systems/genetics*; RNA, Guide, CRISPR-Cas Systems; Rad51 Recombinase/genetics*; Mice, Inbred C57BL; Disease Models, Animal; Recombination, Genetic
- From: Chinese Journal of Biotechnology 2023;39(7):3003-3014
- CountryChina
- Language:Chinese
- Abstract: The generation of a tau-V337M point mutation mouse model using gene editing technology can provide an animal model with fast disease progression and more severe symptoms, which facilitate the study of pathogenesis and treatment of Alzheimer's disease (AD). In this study, single guide RNAs (sgRNA) and single-stranded oligonucleotides (ssODN) were designed and synthesized in vitro. The mixture of sgRNA, Cas9 protein and ssODN was microinjected into the zygotes of C57BL/6J mice. After DNA cutting and recombination, the site homologous to human 337 valine (GTG) in exon 11 was mutated into methionine (ATG). In order to improve the efficiency of recombination, a Rad51 protein was added. The female mice mated with the nonvasectomy male mice were used as the surrogates. Subsequently, the 2-cell stage gene edited embryos were transferred into the unilateral oviduct, and the F0 tau-V337M mutation mice were obtained. Higher mutation efficiency could be obtained by adding Rad51 protein. The F0 tau-V337M point mutation mice can pass the mutation on to the F1 generation mice. In conclusion, this study successfully established the first tau-V337M mutation mouse by using Cas9, ssODN and Rad51. These results provide a new method for developing AD mice model which can be used in further research on the pathogenesis and treatment of AD.
